Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Present and future therapies of hepatitis B: From discovery to cure.

Identifieur interne : 002684 ( PubMed/Corpus ); précédent : 002683; suivant : 002685

Present and future therapies of hepatitis B: From discovery to cure.

Auteurs : T Jake Liang ; Timothy M. Block ; Brian J. Mcmahon ; Marc G. Ghany ; Stephan Urban ; Ju-Tao Guo ; Stephen Locarnini ; Fabien Zoulim ; Kyong-Mi Chang ; Anna S. Lok

Source :

RBID : pubmed:26239691

English descriptors

Abstract

Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million people worldwide. While treatment for HBV has improved, HBV patients often require lifelong therapies and cure is still a challenging goal. Recent advances in technologies and pharmaceutical sciences have heralded a new horizon of innovative therapeutic approaches that are bringing us closer to the possibility of a functional cure of chronic HBV infection. In this article, we review the current state of science in HBV therapy and highlight new and exciting therapeutic strategies spurred by recent scientific advances. Some of these therapies have already entered into clinical phase, and we will likely see more of them moving along the development pipeline.

DOI: 10.1002/hep.28025
PubMed: 26239691

Links to Exploration step

pubmed:26239691

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Present and future therapies of hepatitis B: From discovery to cure.</title>
<author>
<name sortKey="Liang, T Jake" sort="Liang, T Jake" uniqKey="Liang T" first="T Jake" last="Liang">T Jake Liang</name>
<affiliation>
<nlm:affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Block, Timothy M" sort="Block, Timothy M" uniqKey="Block T" first="Timothy M" last="Block">Timothy M. Block</name>
<affiliation>
<nlm:affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Brian J" sort="Mcmahon, Brian J" uniqKey="Mcmahon B" first="Brian J" last="Mcmahon">Brian J. Mcmahon</name>
<affiliation>
<nlm:affiliation>National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ghany, Marc G" sort="Ghany, Marc G" uniqKey="Ghany M" first="Marc G" last="Ghany">Marc G. Ghany</name>
<affiliation>
<nlm:affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Urban, Stephan" sort="Urban, Stephan" uniqKey="Urban S" first="Stephan" last="Urban">Stephan Urban</name>
<affiliation>
<nlm:affiliation>Department of Infectious Diseases, Molecular Virology and German Center for Infection Diseases, University Hospital Heidelberg, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guo, Ju Tao" sort="Guo, Ju Tao" uniqKey="Guo J" first="Ju-Tao" last="Guo">Ju-Tao Guo</name>
<affiliation>
<nlm:affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Locarnini, Stephen" sort="Locarnini, Stephen" uniqKey="Locarnini S" first="Stephen" last="Locarnini">Stephen Locarnini</name>
<affiliation>
<nlm:affiliation>Hepatology Department, Lyon University and Cancer Research Center of Lyon, INSERM U1052, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name>
<affiliation>
<nlm:affiliation>Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chang, Kyong Mi" sort="Chang, Kyong Mi" uniqKey="Chang K" first="Kyong-Mi" last="Chang">Kyong-Mi Chang</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lok, Anna S" sort="Lok, Anna S" uniqKey="Lok A" first="Anna S" last="Lok">Anna S. Lok</name>
<affiliation>
<nlm:affiliation>Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26239691</idno>
<idno type="pmid">26239691</idno>
<idno type="doi">10.1002/hep.28025</idno>
<idno type="wicri:Area/PubMed/Corpus">002684</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002684</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Present and future therapies of hepatitis B: From discovery to cure.</title>
<author>
<name sortKey="Liang, T Jake" sort="Liang, T Jake" uniqKey="Liang T" first="T Jake" last="Liang">T Jake Liang</name>
<affiliation>
<nlm:affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Block, Timothy M" sort="Block, Timothy M" uniqKey="Block T" first="Timothy M" last="Block">Timothy M. Block</name>
<affiliation>
<nlm:affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Mcmahon, Brian J" sort="Mcmahon, Brian J" uniqKey="Mcmahon B" first="Brian J" last="Mcmahon">Brian J. Mcmahon</name>
<affiliation>
<nlm:affiliation>National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Ghany, Marc G" sort="Ghany, Marc G" uniqKey="Ghany M" first="Marc G" last="Ghany">Marc G. Ghany</name>
<affiliation>
<nlm:affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Urban, Stephan" sort="Urban, Stephan" uniqKey="Urban S" first="Stephan" last="Urban">Stephan Urban</name>
<affiliation>
<nlm:affiliation>Department of Infectious Diseases, Molecular Virology and German Center for Infection Diseases, University Hospital Heidelberg, Heidelberg, Germany.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Guo, Ju Tao" sort="Guo, Ju Tao" uniqKey="Guo J" first="Ju-Tao" last="Guo">Ju-Tao Guo</name>
<affiliation>
<nlm:affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Locarnini, Stephen" sort="Locarnini, Stephen" uniqKey="Locarnini S" first="Stephen" last="Locarnini">Stephen Locarnini</name>
<affiliation>
<nlm:affiliation>Hepatology Department, Lyon University and Cancer Research Center of Lyon, INSERM U1052, Lyon, France.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Zoulim, Fabien" sort="Zoulim, Fabien" uniqKey="Zoulim F" first="Fabien" last="Zoulim">Fabien Zoulim</name>
<affiliation>
<nlm:affiliation>Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, VIC, Australia.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Chang, Kyong Mi" sort="Chang, Kyong Mi" uniqKey="Chang K" first="Kyong-Mi" last="Chang">Kyong-Mi Chang</name>
<affiliation>
<nlm:affiliation>Department of Medicine, Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.</nlm:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Lok, Anna S" sort="Lok, Anna S" uniqKey="Lok A" first="Anna S" last="Lok">Anna S. Lok</name>
<affiliation>
<nlm:affiliation>Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Hepatology (Baltimore, Md.)</title>
<idno type="eISSN">1527-3350</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral Agents (therapeutic use)</term>
<term>Drug Discovery</term>
<term>Forecasting</term>
<term>Hepatitis B (drug therapy)</term>
<term>Humans</term>
<term>Remission Induction</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Antiviral Agents</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Hepatitis B</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Drug Discovery</term>
<term>Forecasting</term>
<term>Humans</term>
<term>Remission Induction</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million people worldwide. While treatment for HBV has improved, HBV patients often require lifelong therapies and cure is still a challenging goal. Recent advances in technologies and pharmaceutical sciences have heralded a new horizon of innovative therapeutic approaches that are bringing us closer to the possibility of a functional cure of chronic HBV infection. In this article, we review the current state of science in HBV therapy and highlight new and exciting therapeutic strategies spurred by recent scientific advances. Some of these therapies have already entered into clinical phase, and we will likely see more of them moving along the development pipeline.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">26239691</PMID>
<DateCreated>
<Year>2015</Year>
<Month>12</Month>
<Day>16</Day>
</DateCreated>
<DateCompleted>
<Year>2016</Year>
<Month>04</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised>
<Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1527-3350</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>62</Volume>
<Issue>6</Issue>
<PubDate>
<Year>2015</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Hepatology (Baltimore, Md.)</Title>
<ISOAbbreviation>Hepatology</ISOAbbreviation>
</Journal>
<ArticleTitle>Present and future therapies of hepatitis B: From discovery to cure.</ArticleTitle>
<Pagination>
<MedlinePgn>1893-908</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/hep.28025</ELocationID>
<Abstract>
<AbstractText Label="UNLABELLED">Hepatitis B virus (HBV) is a significant global pathogen, infecting more than 240 million people worldwide. While treatment for HBV has improved, HBV patients often require lifelong therapies and cure is still a challenging goal. Recent advances in technologies and pharmaceutical sciences have heralded a new horizon of innovative therapeutic approaches that are bringing us closer to the possibility of a functional cure of chronic HBV infection. In this article, we review the current state of science in HBV therapy and highlight new and exciting therapeutic strategies spurred by recent scientific advances. Some of these therapies have already entered into clinical phase, and we will likely see more of them moving along the development pipeline.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">With growing interest in developing and efforts to develop more effective therapies for HBV, the challenging goal of a cure may be well within reach in the near future.</AbstractText>
<CopyrightInformation>© 2015 by the American Association for the Study of Liver Diseases. This article has been contributed to by U.S. Government employees and their work is in the public domain in the U.S.A.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Liang</LastName>
<ForeName>T Jake</ForeName>
<Initials>TJ</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Block</LastName>
<ForeName>Timothy M</ForeName>
<Initials>TM</Initials>
<AffiliationInfo>
<Affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>McMahon</LastName>
<ForeName>Brian J</ForeName>
<Initials>BJ</Initials>
<AffiliationInfo>
<Affiliation>National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Anchorage, AK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ghany</LastName>
<ForeName>Marc G</ForeName>
<Initials>MG</Initials>
<AffiliationInfo>
<Affiliation>Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Urban</LastName>
<ForeName>Stephan</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Infectious Diseases, Molecular Virology and German Center for Infection Diseases, University Hospital Heidelberg, Heidelberg, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Guo</LastName>
<ForeName>Ju-Tao</ForeName>
<Initials>JT</Initials>
<AffiliationInfo>
<Affiliation>Baruch S. Blumberg Institute, Doylestown, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Locarnini</LastName>
<ForeName>Stephen</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Hepatology Department, Lyon University and Cancer Research Center of Lyon, INSERM U1052, Lyon, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Zoulim</LastName>
<ForeName>Fabien</ForeName>
<Initials>F</Initials>
<AffiliationInfo>
<Affiliation>Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, VIC, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chang</LastName>
<ForeName>Kyong-Mi</ForeName>
<Initials>KM</Initials>
<AffiliationInfo>
<Affiliation>Department of Medicine, Philadelphia Veterans Affairs Medical Center and the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Lok</LastName>
<ForeName>Anna S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo>
<Affiliation>Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>ZIA DK054500-18</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA DK054500-16</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA DK054500-17</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI113267</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>ZIA DK054500-19</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>Z01 DK054517-02</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>R01 AI104636</GrantID>
<Acronym>AI</Acronym>
<Agency>NIAID NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>Z99 DK999999</GrantID>
<Agency>Intramural NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>10</Month>
<Day>27</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Hepatology</MedlineTA>
<NlmUniqueID>8302946</NlmUniqueID>
<ISSNLinking>0270-9139</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2015 Jan;64(1):139-47</RefSource>
<PMID Version="1">24555998</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Opin Virol. 2014 Oct;8:1-9</RefSource>
<PMID Version="1">24814823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Immunol. 2006 Jul 1;177(1):739-47</RefSource>
<PMID Version="1">16785573</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2013 Sep;123(9):3766-76</RefSource>
<PMID Version="1">23908113</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2015 Jan;61(1):260-7</RefSource>
<PMID Version="1">24867799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2013 Jan;87(1):137-47</RefSource>
<PMID Version="1">23055569</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1984 Nov;52(2):396-402</RefSource>
<PMID Version="1">6492255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Curr Top Membr. 2012;70:105-68</RefSource>
<PMID Version="1">23177985</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2014 Dec;61(6):1212-9</RefSource>
<PMID Version="1">25016223</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2246-51</RefSource>
<PMID Version="1">23341589</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Res Rev. 2014 Mar;34(2):301-39</RefSource>
<PMID Version="1">23801557</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Exp Med. 2008 Sep 1;205(9):2111-24</RefSource>
<PMID Version="1">18695005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunotherapy. 2013 May;5(5):497-511</RefSource>
<PMID Version="1">23638745</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2011 Nov;55(5):996-1003</RefSource>
<PMID Version="1">21376091</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2011 Aug;55(2):245-64</RefSource>
<PMID Version="1">21371579</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Gastroenterol Hepatol. 2014 Jan;12(1):16-26</RefSource>
<PMID Version="1">23660419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2007 Dec;46(6):1759-68</RefSource>
<PMID Version="1">18046710</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2013 Feb;58(2):205-9</RefSource>
<PMID Version="1">23159772</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gene Ther. 2006 Jul;13(14):1110-7</RefSource>
<PMID Version="1">16525482</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trends Immunol. 2010 Oct;31(10):391-7</RefSource>
<PMID Version="1">20832362</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(12):e1003784</RefSource>
<PMID Version="1">24367255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013 Sep;9(9):e1003613</RefSource>
<PMID Version="1">24068929</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Liver. 2002 Oct;22(5):419-25</RefSource>
<PMID Version="1">12390477</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antiviral Res. 2011 Nov;92(2):271-6</RefSource>
<PMID Version="1">21871497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Immunol. 2009 Aug;46(13):2640-6</RefSource>
<PMID Version="1">19501403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2014 May;59(5):1726-37</RefSource>
<PMID Version="1">24375637</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Jan;84(1):243-53</RefSource>
<PMID Version="1">19846513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2012 Jun 28;366(26):2443-54</RefSource>
<PMID Version="1">22658127</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2015 May;61(5):1512-22</RefSource>
<PMID Version="1">25348661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Future Virol. 2014;9(6):565-585</RefSource>
<PMID Version="1">25309617</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Oncol. 2014 Nov 20;32(33):3736-43</RefSource>
<PMID Version="1">25287829</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antiviral Res. 2013 May;98(2):158-70</RefSource>
<PMID Version="1">23541872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2010 Jul 16;400(3):323-34</RefSource>
<PMID Version="1">20546753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2013 Feb 9;381(9865):468-75</RefSource>
<PMID Version="1">23234725</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19975-9</RefSource>
<PMID Version="1">19906987</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013;9(6):e1003391</RefSource>
<PMID Version="1">23785279</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Liver Int. 2015 Mar;35(3):805-15</RefSource>
<PMID Version="1">24620920</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Intern Med. 1982 May;96(5):575-9</RefSource>
<PMID Version="1">7073149</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2012 Dec;61(12):1754-64</RefSource>
<PMID Version="1">22157327</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2013 Sep;59(3):450-6</RefSource>
<PMID Version="1">23669281</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Gen Virol. 2007 Feb;88(Pt 2):432-40</RefSource>
<PMID Version="1">17251560</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 1999 Aug;30(2):531-6</RefSource>
<PMID Version="1">10421664</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2012 Sep;86(17):9443-53</RefSource>
<PMID Version="1">22740403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Physiol Res. 2008;57(5):761-7</RefSource>
<PMID Version="1">17949244</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10205-10</RefSource>
<PMID Version="1">17551004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2013 Jun;87(12):6931-42</RefSource>
<PMID Version="1">23576513</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antiviral Res. 2013 Feb;97(2):195-7</RefSource>
<PMID Version="1">23266293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther. 2014 Feb;22(2):303-11</RefSource>
<PMID Version="1">24025750</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2015 Jul;62(1):207-19</RefSource>
<PMID Version="1">25641256</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2012 Sep;143(3):637-45</RefSource>
<PMID Version="1">22710188</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4244-53</RefSource>
<PMID Version="1">25201958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2013 Jun;144(7):1508-17, 1517.e1-10</RefSource>
<PMID Version="1">23415804</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Virology. 1995 Nov 10;213(2):292-9</RefSource>
<PMID Version="1">7491754</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2013 Jun;144(7):1342-4</RefSource>
<PMID Version="1">23710602</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pharm Res. 2008 Jan;25(1):72-86</RefSource>
<PMID Version="1">18074201</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2013 Nov;57(11):5344-54</RefSource>
<PMID Version="1">23959305</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 Feb;83(4):1778-89</RefSource>
<PMID Version="1">19073743</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2015 Jul;62(1):87-100</RefSource>
<PMID Version="1">25808668</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Annu Rev Pathol. 2006;1:23-61</RefSource>
<PMID Version="1">18039107</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2002 Sep;46(9):3057-60</RefSource>
<PMID Version="1">12183271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Liver Dis. 2010 Aug;14(3):409-24</RefSource>
<PMID Version="1">20638022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2010 Jan;6(1):e1000741</RefSource>
<PMID Version="1">20126445</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2006 Mar;130(3):823-37</RefSource>
<PMID Version="1">16530522</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2015 Aug;63(2):320-8</RefSource>
<PMID Version="1">25733157</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Recognit. 2006 Nov-Dec;19(6):542-8</RefSource>
<PMID Version="1">17006877</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2009 May;49(5 Suppl):S45-55</RefSource>
<PMID Version="1">19399792</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Struct Mol Biol. 2010 Feb;17(2):222-9</RefSource>
<PMID Version="1">20062055</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Cell Mol Immunol. 2015 May;12(3):283-91</RefSource>
<PMID Version="1">25363524</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2011 Nov;85(22):11916-27</RefSource>
<PMID Version="1">21900164</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2012 Mar 9;30(12):2212-9</RefSource>
<PMID Version="1">22273662</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2009 Sep;50(3):661-2</RefSource>
<PMID Version="1">19714720</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2007 Dec 12;25(51):8585-97</RefSource>
<PMID Version="1">18031872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2012 Feb;122(2):529-37</RefSource>
<PMID Version="1">22251702</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Invest. 2008 May;118(5):1835-45</RefSource>
<PMID Version="1">18398508</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2012 Aug;56(8):4277-88</RefSource>
<PMID Version="1">22644022</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antivir Ther. 2010;15 Suppl 3:15-24</RefSource>
<PMID Version="1">21041900</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2008;3(7):e2565</RefSource>
<PMID Version="1">18596958</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2004 Oct 7;351(15):1521-31</RefSource>
<PMID Version="1">15470215</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 1997 Dec;71(12):9392-9</RefSource>
<PMID Version="1">9371599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Clin Virol. 2005 Feb;32(2):156-61</RefSource>
<PMID Version="1">15653419</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Med Microbiol Immunol. 2012 Nov;201(4):449-61</RefSource>
<PMID Version="1">22965171</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2013 Jan;9(1):e1003125</RefSource>
<PMID Version="1">23349632</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2009 Sep;83(18):9321-8</RefSource>
<PMID Version="1">19570861</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2006 May 22;24(21):4482-9</RefSource>
<PMID Version="1">16310901</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2008 Jan;134(1):239-47</RefSource>
<PMID Version="1">18166356</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2014 Oct;61(4):777-84</RefSource>
<PMID Version="1">24915612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2004 Mar 19;303(5665):1829</RefSource>
<PMID Version="1">15031497</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Infect Dis. 2014 Dec 15;59(12):1714-23</RefSource>
<PMID Version="1">25190434</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Intern Med. 1961 Mar;107:335-43</RefSource>
<PMID Version="1">13764742</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2012 Sep;143(3):619-28.e1</RefSource>
<PMID Version="1">22643350</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2006 Jan 9;24(1):20-6</RefSource>
<PMID Version="1">16198027</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2008 Mar;26(3):335-41</RefSource>
<PMID Version="1">18297057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2014 Apr;146(4):1070-83</RefSource>
<PMID Version="1">24361467</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Intern Med. 2005 Feb 15;142(4):240-50</RefSource>
<PMID Version="1">15710957</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2013 Feb;58(2):225-33</RefSource>
<PMID Version="1">23046671</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Res. 2008;42(1-3):219-32</RefSource>
<PMID Version="1">19066740</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 1998 Dec;42(12):3179-86</RefSource>
<PMID Version="1">9835512</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Liver Int. 2009 Jan;29 Suppl 1:108-15</RefSource>
<PMID Version="1">19207973</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2013 Jul;87(14):7977-91</RefSource>
<PMID Version="1">23678176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2014 Jul;147(1):48-64</RefSource>
<PMID Version="1">24768844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2014 May;146(5):1240-8</RefSource>
<PMID Version="1">24462735</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Jun;81(11):5841-9</RefSource>
<PMID Version="1">17376925</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antiviral Res. 2007 Nov;76(2):168-77</RefSource>
<PMID Version="1">17709147</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Vaccine. 2014 Sep 3;32(39):4925-31</RefSource>
<PMID Version="1">25045824</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Intern Med. 2002 Jul 2;137(1):1-10</RefSource>
<PMID Version="1">12093239</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2012;7(6):e39179</RefSource>
<PMID Version="1">22761734</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2010 Oct;52(4):1242-50</RefSource>
<PMID Version="1">20658465</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2003 Feb 7;299(5608):893-6</RefSource>
<PMID Version="1">12574631</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Mol Biol. 2001 Mar 16;307(1):183-96</RefSource>
<PMID Version="1">11243813</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2014 Apr;60(4):723-31</RefSource>
<PMID Version="1">24295872</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Occup Med (Lond). 2011 Dec;61(8):531-40</RefSource>
<PMID Version="1">22114089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2005 Jun 30;352(26):2682-95</RefSource>
<PMID Version="1">15987917</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2010 Sep;84(18):9332-40</RefSource>
<PMID Version="1">20610715</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2004 Jun;126(7):1750-8</RefSource>
<PMID Version="1">15188170</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2013 Jul;58(1):43-53</RefSource>
<PMID Version="1">23292963</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatology. 2002 Mar;35(3):673-9</RefSource>
<PMID Version="1">11870383</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>N Engl J Med. 2004 Sep 16;351(12):1206-17</RefSource>
<PMID Version="1">15371578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15655-60</RefSource>
<PMID Version="1">12432097</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antimicrob Agents Chemother. 2015 Feb;59(2):1273-81</RefSource>
<PMID Version="1">25512416</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2012 Mar;12(3):201-13</RefSource>
<PMID Version="1">22362353</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 1994 Jul 30;344(8918):342</RefSource>
<PMID Version="1">7914291</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2003 Jul;125(1):9-18</RefSource>
<PMID Version="1">12851866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2001 Jan;75(1):311-22</RefSource>
<PMID Version="1">11119601</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2005 Jun;128(7):1890-7</RefSource>
<PMID Version="1">15940624</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Hepatol Int. 2008 Sep;2(3):263-83</RefSource>
<PMID Version="1">19669255</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Rev Immunol. 2008 Jul;8(7):559-68</RefSource>
<PMID Version="1">18575461</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Proc Natl Acad Sci U S A. 2005 Jun 7;102(23):8138-43</RefSource>
<PMID Version="1">15928089</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Immunol Rev. 2015 Jan;263(1):68-89</RefSource>
<PMID Version="1">25510272</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2011 Jan;54(1):12-8</RefSource>
<PMID Version="1">20888661</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Ther Nucleic Acids. 2013 Aug 13;2:e114</RefSource>
<PMID Version="1">23941866</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS One. 2014;9(5):e97579</RefSource>
<PMID Version="1">24827459</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Elife. 2014;3. doi: 10.7554/eLife.00049</RefSource>
<PMID Version="1">25409679</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gastroenterology. 2013 Aug;145(2):456-65</RefSource>
<PMID Version="1">23639914</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2012 Mar;61(3):333-6</RefSource>
<PMID Version="1">22147510</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Hepatol. 2015 Feb;62(2):486-91</RefSource>
<PMID Version="1">25308176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Science. 2014 Mar 14;343(6176):1221-8</RefSource>
<PMID Version="1">24557838</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Structure. 2013 Aug 6;21(8):1406-16</RefSource>
<PMID Version="1">23871485</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Antivir Ther. 2007;12(8):1285-94</RefSource>
<PMID Version="1">18240868</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Invest Med. 1993 Jun;16(3):226-36</RefSource>
<PMID Version="1">8365050</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Nat Biotechnol. 2003 Jun;21(6):639-44</RefSource>
<PMID Version="1">12740585</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mol Immunol. 2015 Feb;63(2):320-7</RefSource>
<PMID Version="1">25193323</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Pathog. 2009 Feb;5(2):e1000313</RefSource>
<PMID Version="1">19247441</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Virol. 2007 Apr;81(8):4215-25</RefSource>
<PMID Version="1">17287266</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Gut. 2015 Dec;64(12):1961-71</RefSource>
<PMID Version="1">25429051</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D055808" MajorTopicYN="N">Drug Discovery</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005544" MajorTopicYN="N">Forecasting</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006509" MajorTopicYN="N">Hepatitis B</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012074" MajorTopicYN="N">Remission Induction</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2015</Year>
<Month>03</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>07</Month>
<Day>31</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>8</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2016</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26239691</ArticleId>
<ArticleId IdType="doi">10.1002/hep.28025</ArticleId>
<ArticleId IdType="pmc">PMC4681668</ArticleId>
<ArticleId IdType="mid">NIHMS725423</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002684 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002684 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26239691
   |texte=   Present and future therapies of hepatitis B: From discovery to cure.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26239691" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024